---
title: Improve walking through transcranial stimulation
nct_id: NCT07182058
phase: PHASE1, PHASE2
status: RECRUITING
sponsor: "U: The Mind Company"
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07182058"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07182058"
last_fetched: "2026-05-10T14:04:43.245Z"
source: "Parkinson's Pathways (curated)"
---
# Improve walking through transcranial stimulation

**Goal (in five words):** Improve walking through transcranial stimulation

**Official Title:** Virtual Remote Assessment of Transcranial Electrical Stimulation for Parkinson's Disease Motor Symptoms

**Trial ID:** [NCT07182058](https://clinicaltrials.gov/study/NCT07182058)

## Key Facts

- **Phase:** PHASE1, PHASE2
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** U: The Mind Company
- **Target Enrollment:** 30 participants
- **Start Date:** 2026-01-01
- **Completion Date:** 2026-03-01
- **Conditions:** PARKINSON DISEASE (Disorder)
- **Interventions:** Transcranial Electrical Stimulation Device
- **Intervention Types:** DEVICE

## Summary For Families

It aims to ease motor symptoms like tremor, slowness, and stiffness by testing whether remotely delivered transcranial electrical stimulation can safely improve movement in people with Parkinson's. The device sends gentle, low-level electrical currents through the scalp to tweak the excitability of motor brain circuits, sessions are done at home with telehealth supervision, and it is studied as an add-on rather than a replacement for levodopa or other Parkinson's medications so participants need a stable regimen. Looking for adults 18 to 80 with Parkinson's at Hoehn and Yahr stages 1 to 4 who have stable meds and reliable internet; people with metal head or neck implants, a history of seizures, recent stroke, pregnancy, severe cognitive impairment, serious skin problems at electrode sites, or current participation in other trials are excluded.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 80 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Adults 18-80 years with confirmed diagnosis of Parkinson's Disease
* Hoehn \& Yahr stages 1-4
* Stable medication regimen for 4+ weeks prior to enrollment
* Reliable internet access and telehealth capability
* Ability to provide informed consent
* Willingness to comply with treatment protocols and follow-up procedures

Exclusion Criteria:

* Metallic head/neck implants (excluding dental fillings)
* Pregnancy or nursing status
* Severe skin conditions at electrode placement sites
* History of epilepsy or seizures (unless technology specifically indicated)
* Recent stroke or traumatic brain injury (within 6 months)
* Severe cognitive impairment preventing treatment understanding
* Any neurological disorders contraindicating transcranial electrical stimulation
* Current participation in other clinical trials
* Inability to commit to full treatment and follow-up schedule
```

## Locations (1)

- U LLC Headquarters, Cleveland, Ohio, United States _(41.4995, -81.6954)_
  - Mohammed h Abouelsoud — (CONTACT) — mo@uthemind.com
  - Hanual Bhandari, MD — (CONTACT)

---

*Canonical: https://parkinsonspathways.com/trial/NCT07182058*  
*HTML version: https://parkinsonspathways.com/trial/NCT07182058*  
*Source data: https://clinicaltrials.gov/study/NCT07182058*